Novo Holdings Invests in Superconductors Amid EU Push for Fusion
Kasim Kutay, chief executive officer of Novo Holdings A/S.
Photographer: Chris Ratcliffe/BloombergNovo Holdings, the controlling shareholder of Novo Nordisk A/S, is topping up an investment in a Danish company specialized in superconductor technology, as part of an effort to accelerate new energy resources in Europe.
The investor, which manages roughly $100 billion including its stake in Novo Nordisk, led a €40 million ($47 million) funding round to support growth at Subra A/S. It was joined by Germany’s government-backed innovation agency SPRIND, as well as Maj Invest, according to an April 10 statement.